Rankings
▼
Calendar
JAZZ Q1 2016 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$336M
Gross Profit
$313M
93.0% margin
Operating Income
$121M
36.1% margin
Net Income
$74M
22.1% margin
EPS (Diluted)
$1.21
Cash Flow
Operating Cash Flow
$144M
Free Cash Flow
$132M
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$3.5B
Total Liabilities
$1.9B
Stockholders' Equity
$1.6B
Cash & Equivalents
$980M
Revenue Segments
Defitelio
$18M
100%
Geographic Segments
UNITED STATES
$306M
91%
Europe
$25M
7%
Other Countries
$5M
2%
← FY 2016
All Quarters
Q2 2016 →
